Loading

Optimizing the Investability of Your Lead Program: Data-Driven Approaches for Pipeline Prioritization

June 04, 2024
Breakout Session
Business Development and Investment
32AB
Identifying a lead indication, development candidate selection and pipeline prioritization are critical decisions for all biotech companies. This panel will focus on key strategies and considerations to optimize the transition from the preclinical stage in development to clinical stage. Critical topics this discussion will cover highlight data-driven approaches to increase probability of success, with particular attention to trade-offs between speed to clinic and additional data, attention to capital needs/constraints, speed to market and market size, appropriate and timely regulatory path identification, strategies to engage with the FDA, as well as some IRA considerations.
Speakers
Drew Cutshaw, MD
Senior Associate, Medical Officer
Pappas Capital
Speakers
Lauren Crawford Shaver
Head of Healthcare and Life Sciences for the Americas, Senior Managing Director
FTI Consulting
Ben Davis
Vice President, Corporate Alliances
IQVIA
Mike Grey
Chairman
Plexium
Susan Lenderts
Head of Life Sciences
SAS Institute, INC
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS